Assertion: lymphocyte | /r/CapableOf | traffic through different mechanisms
Facets:
Source sentences:
text: α4β7 integrin (vedolizumab), and a small molecule antagonist of sphingosine-1-phosphate receptor (fingolimod), all of which inhibit lymphocyte trafficking through different mechanisms, can thus be used in the clinics for the treatment of inflammatory diseases.